The Impact of Disclosure on Health and Related Outcomes in Human Immunodeficiency Virus-Infected Children: A Literature Review
被引:20
|
作者:
Odiachi, Angela
论文数: 0引用数: 0
h-index: 0
机构:
Univ North Carolina Chapel Hill, Dept Hlth Policy & Management, Chapel Hill, NC 27599 USAUniv North Carolina Chapel Hill, Dept Hlth Policy & Management, Chapel Hill, NC 27599 USA
Odiachi, Angela
[1
]
机构:
[1] Univ North Carolina Chapel Hill, Dept Hlth Policy & Management, Chapel Hill, NC 27599 USA
human immunodeficiency virus;
children living with human immunodeficiency virus;
pediatric disclosure;
health outcomes;
review;
HIV STATUS;
SOUTH-AFRICA;
ADOLESCENTS;
ADJUSTMENT;
PREVALENCE;
DIAGNOSIS;
TIME;
D O I:
10.3389/fpubh.2017.00231
中图分类号:
R1 [预防医学、卫生学];
学科分类号:
1004 ;
120402 ;
摘要:
This review explores the association between pediatric human immunodeficiency virus (HIV) disclosure and health and related outcomes among children living with HIV. A multi-stage process was used to search for relevant articles on the ISI Web of Knowledge database. Fifteen articles met the inclusion criteria. Five major outcomes emerged from children's knowledge of their HIV-seropositive status: physical/physiological outcomes; adherence to antiretroviral therapy; psychosocial outcomes; sexual and reproductive health, including HIV prevention outcomes; and disclosure of status by the children. Disclosure of a child's HIV status to the child has value in terms of positive health outcomes for the child, such as better adherence and slower disease progression-albeit the different studies did not always reach the same conclusions, and some suggest negative health outcomes, such as increased psychiatric hospitalization. Yet, there does not seem to be a systematic or coherent system for child disclosure. One recommendation from this review, therefore, is for government and program policies and guidelines that will promote child HIV disclosure in order to address the current low rates of disclosure in sub-Saharan Africa (SSA). More rigorous and longitudinal studies on the outcomes of disclosure, with larger sample sizes, and in SSA, are also needed.
机构:
US FDA, Div Antiviral Drug Prod, Ctr Drug Evaluat & Res, Rockville, MD USAUS FDA, Div Antiviral Drug Prod, Ctr Drug Evaluat & Res, Rockville, MD USA
Baylor, MS
Johann-Liang, R
论文数: 0引用数: 0
h-index: 0
机构:
US FDA, Div Antiviral Drug Prod, Ctr Drug Evaluat & Res, Rockville, MD USAUS FDA, Div Antiviral Drug Prod, Ctr Drug Evaluat & Res, Rockville, MD USA
机构:
Center of Excellence for Innovation and Endoscopy in Gastrointestinal Oncology, Division of Gastroenterology, Department of Medicine, Faculty of Medicine, Chulalongkorn UniversityCenter of Excellence for Innovation and Endoscopy in Gastrointestinal Oncology, Division of Gastroenterology, Department of Medicine, Faculty of Medicine, Chulalongkorn University
Roongruedee Chaiteerakij
论文数: 引用数:
h-index:
机构:
Anapat Sanpawat
Anchalee Avihingsanon
论文数: 0引用数: 0
h-index: 0
机构:
Medical Department, The HIV Netherlands Australia Thailand Research CollaborationCenter of Excellence for Innovation and Endoscopy in Gastrointestinal Oncology, Division of Gastroenterology, Department of Medicine, Faculty of Medicine, Chulalongkorn University